Alexandra M. Adams, MD, MPH
Complex General Surgical Oncology Fellow
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Teppei Miyakawa, MD
Postdoctoral Fellow
Department of Colorectal Oncology Surgery, MD Anderson Cancer Center
houston, Texas, United States
Kentaro Ochiai, MD, PhD
Postdoctoral Fellow
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Jagan Ramamurthy, MD
Fellow
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Tsuyoshi Konishi, MD, PhD
Associate Professor
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Jessie Yu, MD
Department of Plastic Surgery / MD Anderson Cancer Center
Houston, Texas, United States
Christopher Nguyen, MD
Assistant Professor
Department of Plastic Surgery / MD Anderson Cancer Center
Houston, Texas, United States
David M. Adelman, MD PhD FACS (he/him/his)
Professor
Department of Plastic Surgery / MD Anderson Cancer Center
houston, Texas, United States
Brian K. Bednarski, MD (he/him/his)
Associate Professor
MD Anderson Cancer Center
Houston, Texas, United States
George J. Chang, MD, MSc, MHCM
Professor
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Jessica J. Lie, MD, MPH
Complex General Surgical Oncology Fellow
MD Anderson Cancer Center
houston, Texas, United States
Extended pelvic resections beyond total mesorectal excision (bTME) are increasingly performed for locally advanced or recurrent rectal cancer to achieve margin-negative resection. These operations carry a high risk of pelvic morbidity, including the constellation of complications known as Empty Pelvis Syndrome (EPS). The incidence and risk factors for EPS following bTME remain poorly defined, particularly across the spectrum of surgical complexity and reconstructive approaches.
Methods:
A retrospective review of a prospectively maintained database identified all patients who underwent bTME for rectal adenocarcinoma at a tertiary cancer center (2006–2023). bTME was defined as resection extending beyond standard TME planes with enbloc organ or vascular resection. Patients with sphincter preservation surgery were excluded. Surgical complexity was categorized using the UK Pelvic Exenteration Lexicon, with high complexity defined by resection of bony structures or the pelvic sidewall. The primary outcome was UK Pelvic Exenteration Network’s EPS-related complications (pelvic abscess, small bowel obstruction, enteroperineal fistula, chronic perineal sinus). Univariable and multivariable analyses identified predictors of EPS.
Results:
Among 478 patients (mean age 58 years; 45.0% female; 40.8% recurrent disease), 176 (36.8%) underwent high-complexity resections. Flap reconstruction was performed in 96.7% (25.1% omental, 59.2% abdominal-based, 11.9% extremity-based, 0.4% both extremity and abdominal-based). Overall, 117 (24.5%) patients had an EPS event of whom 32 (27.3%) required reoperation including late reoperations. EPS events occurred more frequently after high- vs. low-complexity surgery (36.4% vs. 17.6%, p<0.001) and varied by flap type (12.2% none, 28.3% omental, 20.1% abdominal-based, 42.1% extremity-based; p=0.004). On multivariable analysis, high complexity (adjusted OR 2.70, 95% CI 1.69–4.31, p<0.001) and extremity-based flaps (aOR 5.67, 95% CI 1.12–28.7, p=0.040) were independently associated with increased EPS risk.
Conclusions:
EPS events occur in over one-fifth of patients undergoing bTME and is strongly associated with extent of resection and type of reconstruction. These findings highlight the morbidity of aggressive pelvic surgery and emphasize the need for tailored reconstruction and multidisciplinary planning to optimize outcomes and patient counseling.